Literature DB >> 25895972

AP-1 Transcription Factor Serves as a Molecular Switch between Chlamydia pneumoniae Replication and Persistence.

S Krämer1, P Crauwels1, R Bohn1, C Radzimski2, M Szaszák2, M Klinger3, J Rupp4, G van Zandbergen5.   

Abstract

Chlamydia pneumoniae is a Gram-negative bacterium that causes acute or chronic respiratory infections. As obligate intracellular pathogens, chlamydiae efficiently manipulate host cell processes to ensure their intracellular development. Here we focused on the interaction of chlamydiae with the host cell transcription factor activator protein 1 (AP-1) and its consequence on chlamydial development. During Chlamydia pneumoniae infection, the expression and activity of AP-1 family proteins c-Jun, c-Fos, and ATF-2 were regulated in a time- and dose-dependent manner. We observed that the c-Jun protein and its phosphorylation level significantly increased during C. pneumoniae development. Small interfering RNA knockdown of the c-Jun protein in HEp-2 cells reduced the chlamydial load, resulting in smaller inclusions and significantly lower chlamydial recovery. Furthermore, inhibition of the c-Jun-containing AP-1 complexes using tanshinone IIA changed the replicative infection phenotype into a persistent one. Tanshinone IIA-dependent persistence was characterized by smaller, aberrant inclusions, a strong decrease in the chlamydial load, and significantly reduced chlamydial recovery, as well as by the reversibility of the reduced recovery after the removal of tanshinone IIA. Interestingly, not only was tanshinone IIA treatment accompanied by a significant decrease of ATP levels, but fluorescence live cell imaging analysis by two-photon microscopy revealed that tanshinone IIA treatment also resulted in a decreased fluorescence lifetime of protein-bound NAD(P)H inside the chlamydial inclusion, indicating that chlamydial reticulate bodies have decreased metabolic activity. In all, these data demonstrate that the AP-1 transcription factor is involved in C. pneumoniae development, with tanshinone IIA treatment resulting in persistence.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25895972      PMCID: PMC4468534          DOI: 10.1128/IAI.03083-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells.

Authors:  K Wolf; E Fischer; T Hackstadt
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Chlamydia trachomatis persistence in vitro: an overview.

Authors:  Priscilla B Wyrick
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

3.  Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection.

Authors:  W L Beatty; R P Morrison; G I Byrne
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

Review 4.  Targeting inflammation by modulating the Jun/AP-1 pathway.

Authors:  Helia B Schonthaler; Juan Guinea-Viniegra; Erwin F Wagner
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

5.  Enhancement of ATP levels and glucose metabolism during an infection by Chlamydia. NMR studies of living cells.

Authors:  D M Ojcius; H Degani; J Mispelter; A Dautry-Varsat
Journal:  J Biol Chem       Date:  1998-03-20       Impact factor: 5.157

6.  Restricted fusion of Chlamydia trachomatis vesicles with endocytic compartments during the initial stages of infection.

Authors:  Marci A Scidmore; Elizabeth R Fischer; Ted Hackstadt
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

7.  Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro.

Authors:  W L Beatty; G I Byrne; R P Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Host metabolism promotes growth of Chlamydia pneumoniae in a low oxygen environment.

Authors:  Márta Szaszák; Kensuke Shima; Nadja Käding; Michael Hannus; Werner Solbach; Jan Rupp
Journal:  Int J Med Microbiol       Date:  2013-04-06       Impact factor: 3.473

9.  Fluorescence lifetime imaging unravels C. trachomatis metabolism and its crosstalk with the host cell.

Authors:  Márta Szaszák; Philipp Steven; Kensuke Shima; Regina Orzekowsky-Schröder; Gereon Hüttmann; Inke R König; Werner Solbach; Jan Rupp
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

10.  The role of viable but non-infectious developmental forms in chlamydial biology.

Authors:  Nicole Borel; Andreas Pospischil; Alan P Hudson; Jan Rupp; Robert V Schoborg
Journal:  Front Cell Infect Microbiol       Date:  2014-07-24       Impact factor: 5.293

View more
  3 in total

1.  Pleiotropic roles of metallothioneins as regulators of chondrocyte apoptosis and catabolic and anabolic pathways during osteoarthritis pathogenesis.

Authors:  Yoonkyung Won; Youngnim Shin; Churl-Hong Chun; Yongsik Cho; Chul-Won Ha; Jin-Hong Kim; Jang-Soo Chun
Journal:  Ann Rheum Dis       Date:  2016-02-22       Impact factor: 19.103

2.  Arthropod transcriptional activator protein-1 (AP-1) aids tick-rickettsial pathogen survival in the cold.

Authors:  Supreet Khanal; Vikas Taank; John F Anderson; Hameeda Sultana; Girish Neelakanta
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

3.  Assaying Chlamydia pneumoniae Persistence in Monocyte-Derived Macrophages Identifies Dibenzocyclooctadiene Lignans as Phenotypic Switchers.

Authors:  Eveliina Taavitsainen; Maarit Kortesoja; Tanja Bruun; Niklas G Johansson; Leena Hanski
Journal:  Molecules       Date:  2020-01-11       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.